Author:
Li Jiang-hui,Ma Xue-yao,Yi Yun,Li Lu-rao,Xu Zhi-yong,Chang Ying
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Ludwig J, Viggiano TR, McGill DB, et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc, 1980,55(7):434–438
2. Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol, 2015,62(1 Suppl):S47–S64
3. Eslam M, Sanyal AJ, George J, et al. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology, 2020,158(7):1999–2014.e1
4. Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol, 2020,73(1):202–209
5. Wang TY, George J, Zheng MH. Metabolic (dysfunction) associated fatty liver disease: more evidence and a bright future. Hepatobiliary Surg Nutr, 2021,10(6):849–852